Buy Revolax Fine with Lidocaine Online
Revolax Fine with Lidocaine is a hyaluronic acid-based dermal filler specifically formulated for superficial to mid-dermis injections. Its fine consistency makes it perfect for treating fine lines and enhancing sensitive areas such as the lips.
It is developed for the treatment of superficial lines, including crow’s feet, glabellar lines, and neck wrinkles, for a flawless result.
Upon treatment, REVOLAX Fine quickly absorbs into the skin, creating a very natural and healthy look to the injected area and improving overall appearance.
Key Features
- It is the thinnest dermal filler in the REVOLAX range
- Biodegradable, non-animal-based, crystal-clear cross-linked dermal filler
- CE-marked
- Lightweight and high viscoelasticity
Treatment Areas:
- Crow’s feet
- Glabellar lines
- Neck wrinkles
- Lips (Russian Lip Technique)
- Superficial Lines
Composition:
- Hyaluronic Acid concentration: 24mg/mL
- Lidocaine HCl 0.3%
- Volume 1.1ml
- Duration: 9–12 Months
- 80 MPa
Box Contents:
- 1x syringe
- 2x 30G sterile needles
Future of Revolax Fine with Lidocaine
Innovations and Advancements
Ongoing research and development aim to improve the formulation and application techniques of Revolax Fine with Lidocaine, potentially increasing its efficacy and safety even further.
Predictions for Future Use
As non-surgical cosmetic procedures continue to grow in popularity, Revolax Fine with Lidocaine is expected to remain a leading choice for patients seeking subtle facial enhancements without surgery.
Conclusion
Revolax Fine offers a subtle and effective solution for those looking to smooth fine lines and enhance delicate areas such as the lips. Its unique properties, combined with its proven efficacy and the added benefit of lidocaine for comfort, make it an excellent option for various aesthetic treatments. By understanding its benefits, potential side effects, and proper administration techniques, patients and practitioners can achieve optimal outcomes with Revolax Fine.
Reviews
There are no reviews yet.